Angeles Alvarez Secord

Angeles Alvarez Secord

UNVERIFIED PROFILE

Are you Angeles Alvarez Secord?   Register this Author

Register author
Angeles Alvarez Secord

Angeles Alvarez Secord

Publications by authors named "Angeles Alvarez Secord"

Are you Angeles Alvarez Secord?   Register this Author

100Publications

2034Reads

27Profile Views

European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies.

Gynecol Oncol 2020 Feb 3;156(2):265-270. Epub 2020 Jan 3.

Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.11.010DOI Listing
February 2020

Differential expression of immune related genes in high-grade ovarian serous carcinoma.

Gynecol Oncol 2020 Jan 7. Epub 2020 Jan 7.

Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.12.019DOI Listing
January 2020

Patient preferences for maintenance PARP inhibitor therapy in ovarian cancer treatment.

Gynecol Oncol 2020 Jan 22. Epub 2020 Jan 22.

Duke Cancer Institute, Duke University Medical Center, Durham, NC, United States of America; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, United States of America; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.01.026DOI Listing
January 2020

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.

N Engl J Med 2019 11;381(20):1929-1939

From the University of Texas M.D. Anderson Cancer Center, Houston (R.L.C., K.B.-E.); Women's Cancer Center of Nevada, Las Vegas (N.M.S.); NRG Oncology Statistical and Data Management Center, Roswell Park Cancer Institute, Buffalo (D.E., H.Q.H., M.F.B.), and Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York (P.S.) - both in New York; the University of Cincinnati, University of Cincinnati Cancer Institute, Cincinnati (T.J.H.); the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore (D.K.A.); Seoul National University College of Medicine (J.-W.K.), Samsung Medical Center, Sungkyunkwan University School of Medicine (B.-G.K.), and Asan Medical Center, University of Ulsan College of Medicine (J.-H.N.), Seoul, and the Research Institute and Hospital, National Cancer Center, Goyang (S.-Y.P.) - all in South Korea; Saitama Medical University International Medical Center, Hidaka, Japan (K.F.); the University of Oklahoma Health Sciences Center, Oklahoma City (J.L.W., R.S.M.); National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, U.S. Oncology Research, and Metro-Minnesota Community Oncology Research Consortium, Minneapolis (A.C.C.); Duke Cancer Institute, Duke University Medical Center, Durham, NC (A.A.S.); Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.R.); Gynecologic Cancer Program, California Pacific-Palo Alto Medical Foundation, Sutter Research Institute, San Francisco (J.K.C.); Women and Infants Hospital, Providence, RI (P.D.); the University of Colorado School of Medicine, Aurora, and Denver Health Medical Center, Denver (S.A.D.); Ohio State University, Columbus (D.E.C.); and the University of California, Irvine, Orange (K.S.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1902626DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941470PMC
November 2019

Ovarian cancer: time to move beyond one size fits all.

Lancet Oncol 2019 Jun 7;20(6):754-755. Epub 2019 May 7.

Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30285-2DOI Listing
June 2019

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking of epithelial ovarian cancer following neoadjuvant chemotherapy.

Gynecol Oncol 2019 05 1;153(2):376-380. Epub 2019 Feb 1.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, United States of America; Duke Cancer Institute, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.01.025DOI Listing
May 2019

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.

Lancet Oncol 2019 May 1;20(5):636-648. Epub 2019 Apr 1.

Division of Gynecologic Oncology, Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine at St Joseph's Hospital, Phoenix, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30029-4DOI Listing
May 2019

The association between progesterone receptor expression and survival in women with adult granulosa cell tumors.

Gynecol Oncol 2019 04 18;153(1):74-79. Epub 2019 Jan 18.

Division of Gynecologic Oncology, Duke Cancer Institute, Durham, NC, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.01.016DOI Listing
April 2019

Ovarian Cancer: Clinical Trial Breakthroughs and Impact on Management.

Obstet Gynecol Clin North Am 2019 Mar;46(1):67-88

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Box 3079, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898545183009
Publisher Site
http://dx.doi.org/10.1016/j.ogc.2018.09.005DOI Listing
March 2019

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma.

Obstet Gynecol 2019 02;133(2):245-254

Cleveland Clinic Foundation and Case Western Reserve University, Cleveland, Ohio; NRG Oncology Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York; The Ohio State University, Columbus, Ohio; the University of Minnesota, Minneapolis, Minnesota; Duke University Hospital; Durham, North Carolina; the University of California at Irvine, Orange, California; the University of Iowa Hospital, Iowa City, Iowa; Washington University in St. Louis School of Medicine, St. Louis, Missouri; ANZGOG, Australia-New Zealand Gynaecological Oncology Group, Sydney, Australia; the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Community Health Network and Indiana University School of Medicine, Indianapolis, Indiana; Walter Reed Army Medical Center; Bethesda, Maryland; Tacoma General Hospital, Tacoma, Washington; Moffitt Cancer Center, Tampa, Florida; the University of Colorado School of Medicine at Denver, Aurora, Colorado; Cancer Treatment Centers of America, Philadelphia Pennsylvania; NYU Clinical Cancer Center, New York, New York; Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland; US Oncology Research, Arizona Oncology, Tucson, Arizona; the University of Pennsylvania Medical Center, Philadelphia, Pennsylvania; and The Ohio State University Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000003086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551603PMC
February 2019

Hysterectomy with sentinel lymph node biopsy in the setting of pre-operative diagnosis of endometrial intraepithelial neoplasia: A cost-effectiveness analysis.

Gynecol Oncol 2018 12 23;151(3):506-512. Epub 2018 Sep 23.

Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, United States of America; Duke Cancer Institute, United States of America. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258183123
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2018.09.020DOI Listing
December 2018

Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy.

Gynecol Oncol Res Pract 2018 30;5. Epub 2018 Oct 30.

3Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710 USA.

View Article

Download full-text PDF

Source
https://gynoncrp.biomedcentral.com/articles/10.1186/s40661-0
Publisher Site
http://dx.doi.org/10.1186/s40661-018-0065-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208173PMC
October 2018

Maintenance treatment of recurrent ovarian cancer: Is it ready for prime time?

Cancer Treat Rev 2018 Sep 5;69:53-65. Epub 2018 Jun 5.

Gynecology Oncology, Duke Cancer Institute, Durham, NC, United States; The Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372183009
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2018.06.001DOI Listing
September 2018

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.

J Clin Oncol 2018 07 27;36(20):2044-2051. Epub 2018 Mar 27.

Amanda N. Fader, Johns Hopkins School of Medicine; Dana M. Roque, University of Maryland; Paul Celano, Greater Baltimore Medical Center, Baltimore; William Lowery, Walter Reed Medical Center, Bethesda, MD; Eric Siegel, University of Arkansas for Medical Sciences, Little Rock, AR; Natalia Buza, Pei Hui, Osama Abdelghany, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Peter E. Schwartz, and Alessandro D. Santin, Yale University School of Medicine, New Haven, CT; Setsuko K. Chambers, University of Arizona, Tucson, AZ; Angeles Alvarez Secord and Laura Havrilesky, Duke University School of Medicine, Durham, NC; David M. O'Malley and Floor Backes, The Ohio State University School of Medicine, Columbus, OH; Nicole Nevadunsky, Montefiore Medical Center, Bronx, NY; Babak Edraki, John Muir Medical Center, Walnut Creek, CA; Dirk Pikaart, Penrose Cancer Center-St Francis, Colorado Springs, CO; and Karim S. ElSahwi, Meridian Health, Neptune, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5966DOI Listing
July 2018

Cabozantinib in ovarian clear cell cancers: UnMET expectations.

Gynecol Oncol 2018 07;150(1):1-2

Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2018.06.006DOI Listing
July 2018

ASCO Value Framework Highlights the Relative Value of Treatment Options in Ovarian Cancer.

J Oncol Pract 2017 12 10;13(12):e1030-e1039. Epub 2017 Oct 10.

Duke University Medical Center, Durham, NC; University of California, Los Angeles, Cedars Sinai Medical Center, Los Angeles, CA; Ohio State University Medical Center, Columbus, OH; and Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.025106DOI Listing
December 2017

Use of a novel sentinel lymph node mapping algorithm reduces the need for pelvic lymphadenectomy in low-grade endometrial cancer.

Gynecol Oncol 2017 12 19;147(3):535-540. Epub 2017 Oct 19.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Duke Cancer Institute, Durham, NC, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.10.020DOI Listing
December 2017

Maintenance Poly (ADP-ribose) Polymerase Inhibitor Therapy for Ovarian Cancer: Precision Oncology or One Size Fits All?

J Clin Oncol 2017 Dec 26;35(36):3999-4002. Epub 2017 Oct 26.

Andrew Berchuck, Angeles Alvarez Secord, Haley A. Moss, and Laura J. Havrilesky, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.5752DOI Listing
December 2017

Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer.

J Oncol Pract 2017 02 3;13(2):e120-e129. Epub 2017 Jan 3.

Duke University Medical Center, Durham, NC; and Ohio State University Medical Center, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2016.011866DOI Listing
February 2017

Analysis of in vitro chemoresponse assays in endometrioid endometrial adenocarcinoma: an observational ancillary analysis.

Gynecol Oncol Res Pract 2016 1;3:13. Epub 2016 Dec 1.

Division of Gynecologic Oncology, Duke University Medical Center, Duke University, DUMC Box 3079, Durham, NC 27710 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-016-0032-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134103PMC
December 2016

Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women: A Cost-Effectiveness Analysis.

Obstet Gynecol 2016 10;128(4):747-53

Divisions of Gynecologic Oncology and Clinical and Epidemiologic Research, Department of Obstetrics and Gynecology, Duke Clinical Research Institute, and the Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000001616DOI Listing
October 2016

Performance of sentinel lymph node biopsy in high-risk endometrial cancer.

Gynecol Oncol Rep 2016 Aug 19;17:69-71. Epub 2016 Apr 19.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, United States; Duke Cancer Institute, Durham, NC, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2016.04.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941561PMC
August 2016

Is Intraperitoneal Chemotherapy Dead?

Obstet Gynecol 2016 06;127(6):983-4

Drs. Secord and Havrilesky are from the Division of Gynecology Oncology, Department of Obstetrics and Gynecology, at the Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina; e-mail: and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000001461DOI Listing
June 2016

Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.

Gynecol Oncol Res Pract 2015 12;2. Epub 2015 May 12.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40661-015-0008-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4880836PMC
May 2016

Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis.

Gynecol Oncol 2016 Jan 31;140(1):184-90. Epub 2015 Oct 31.

Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258153016
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.10.020DOI Listing
January 2016

A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.

Gynecol Oncol 2015 Nov 6;139(2):275-82. Epub 2015 Sep 6.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Minnesota, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258153012
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2015.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189638PMC
November 2015

Prognostic significance of differential expression of angiogenic genes in women with high-grade serous ovarian carcinoma.

Gynecol Oncol 2015 Oct 7;139(1):23-9. Epub 2015 Aug 7.

Division of Gynecology Oncology, Department of Obstetrics and Gynecology, Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.08.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587300PMC
October 2015

Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis.

Gynecol Oncol 2015 Aug 30;138(2):267-71. Epub 2015 May 30.

Gynecologic Oncology, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.05.038DOI Listing
August 2015

Patient preferences in advanced or recurrent ovarian cancer.

Cancer 2014 Dec 4;120(23):3651-9. Epub 2014 Aug 4.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429767PMC
December 2014

The search for biomarkers to direct antiangiogenic treatment in epithelial ovarian cancer.

Gynecol Oncol 2014 Nov 30;135(2):349-58. Epub 2014 Aug 30.

Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.033DOI Listing
November 2014

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.

Am J Obstet Gynecol 2014 Jul 12;211(1):68.e1-8. Epub 2014 Feb 12.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Women and Infants Hospital, Brown University, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2014.02.009DOI Listing
July 2014

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer.

Int J Womens Health 2014 13;6:289-300. Epub 2014 Mar 13.

Division of Gynecologic Oncology, Duke Cancer Institute, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJWH.S49781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958497PMC
June 2014

Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway.

Cancer Treat Rev 2014 May 22;40(4):507-12. Epub 2013 Nov 22.

Duke University Medical Center (DUMC) 3079, Durham, NC 27710, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.11.004DOI Listing
May 2014

Relationship between minimally invasive hysterectomy, pelvic cytology, and lymph vascular space invasion: a single institution study of 458 patients.

Gynecol Oncol 2014 May 28;133(2):211-5. Epub 2014 Feb 28.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA; Duke Cancer Institute, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.02.025DOI Listing
May 2014

Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer.

Int J Gynecol Cancer 2014 May;24(4):670-5

*Division of Gynecologic Oncology, Duke Cancer Institute, Duke University Medical Center, Durham; †University of North Carolina School of Medicine, Chapel Hill; ‡Department of Pathology, Duke University Medical Center, Durham; and §Department of Pathology and Laboratory Medicine and ∥Division of Gynecologic Oncology, University of North Carolina, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545297PMC
May 2014

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.

Gynecol Oncol 2014 Apr;133(1):28-32

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, USA; University of North Carolina Lineberger Comprehensive Cancer Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.01.032DOI Listing
April 2014

Metformin is associated with improved survival in endometrial cancer.

Gynecol Oncol 2014 Feb 22;132(2):438-42. Epub 2013 Nov 22.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, USA; University of North Carolina Lineberger Comprehensive Cancer Center, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.11.021DOI Listing
February 2014

Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: A case report.

Gynecol Oncol Case Rep 2013 16;5:19-21. Epub 2013 Mar 16.

Department of Obstetrics and Gynecology, Duke University Medical Center, USA ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, USA ; Duke Cancer Institute, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S2211338X130002
Publisher Site
http://dx.doi.org/10.1016/j.gynor.2013.03.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862316PMC
December 2013

TP53 Status is Associated with Thrombospondin1 Expression In vitro.

Front Oncol 2013 29;3:269. Epub 2013 Oct 29.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke Cancer Institute, Duke University Medical Center , Durham, NC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810652PMC
November 2013

Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancer.

Cancer 2013 Oct 6;119(20):3653-61. Epub 2013 Aug 6.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, San Antonio Military Medical Center, Fort Sam Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28283DOI Listing
October 2013

Cost-effectiveness of early palliative care intervention in recurrent platinum-resistant ovarian cancer.

Gynecol Oncol 2013 Sep 14;130(3):426-30. Epub 2013 Jun 14.

Duke University Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.06.011DOI Listing
September 2013

Timing of end-of-life care discussion with performance on end-of-life quality indicators in ovarian cancer.

Gynecol Oncol 2013 Jul 13;130(1):156-61. Epub 2013 Apr 13.

Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.04.010DOI Listing
July 2013

Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.

Gynecol Oncol 2013 Jul 13;130(1):64-8. Epub 2013 Apr 13.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine and Siteman Cancer Center, St. Louis, MO, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.04.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870479PMC
July 2013

Image-guided brachytherapy for gynecologic surgeons.

Surg Oncol Clin N Am 2013 Jul 7;22(3):495-509. Epub 2013 Mar 7.

Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2013.02.002DOI Listing
July 2013

Cost-effectiveness of BRCA1 and BRCA2 mutation testing to target PARP inhibitor use in platinum-sensitive recurrent ovarian cancer.

Int J Gynecol Cancer 2013 Jun;23(5):846-52

Division of Gynecologic Oncology, Duke Cancer Institute, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31829527bdDOI Listing
June 2013

Summary of the 44th Annual Meeting on Women's Cancers.

Gynecol Oncol 2013 May;129(2):273-6

Duke University Medical , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.03.028DOI Listing
May 2013

Physical strain and urgent need for ergonomic training among gynecologic oncologists who perform minimally invasive surgery.

Gynecol Oncol 2012 Sep 18;126(3):437-42. Epub 2012 May 18.

Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599–7570, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.05.016DOI Listing
September 2012

Iniparib plus paclitaxel and carboplatin as initial treatment of advanced or recurrent uterine carcinosarcoma: a Gynecologic Oncology Group Study.

Gynecol Oncol 2012 Sep 24;126(3):424-7. Epub 2012 May 24.

Dept. of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.05.024DOI Listing
September 2012

Obesity: Too big a problem to ignore.

Gynecol Oncol 2012 Aug 30;126(2):274-6. Epub 2012 Apr 30.

Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.04.033DOI Listing
August 2012

Quinary debulking for epithelial ovarian cancer.

J Surg Case Rep 2012 Jul 1;2012(7). Epub 2012 Jul 1.

Duke University Medical Center, Durham, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jscr/2012.7.7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649565PMC
July 2012

Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?

Gynecol Oncol 2012 Jul 12;126(1):12-5. Epub 2012 May 12.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.05.003DOI Listing
July 2012

Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer.

Gynecol Oncol 2012 Jun 15;125(3):625-30. Epub 2012 Mar 15.

Department of Obstetrics and Gynecology, Duke University Medical Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.03.015DOI Listing
June 2012

Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer.

Int J Gynecol Cancer 2012 Mar;22(3):348-59

Division of Gynecologic Oncology, Duke Cancer Institute, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0b013e31823c6efdDOI Listing
March 2012